HSBC Holdings’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.8M Sell
31,600
-49,100
-61% -$5.67M ﹤0.01% 1263
2025
Q4
$8.52M Sell
80,700
-38,900
-33% -$3.65M ﹤0.01% 1026
2025
Q3
$9.95M Buy
119,600
+57,200
+92% +$4.71M 0.01% 927
2025
Q2
$4.94M Hold
62,400
﹤0.01% 1166
2025
Q1
$5.6M Sell
62,400
-800
-1% -$74.7K ﹤0.01% 1082
2024
Q4
$6.28M Buy
63,200
+46,300
+274% +$4.77M ﹤0.01% 1060
2024
Q3
$1.92M Sell
16,900
-3,900
-19% -$463K ﹤0.01% 1437
2024
Q2
$2.59M Hold
20,800
﹤0.01% 1296
2024
Q1
$2.74M Sell
20,800
-5,000
-19% -$616K ﹤0.01% 1334
2023
Q4
$2.81M Buy
25,800
+1,700
+7% +$176K ﹤0.01% 1354
2023
Q3
$2.49M Buy
24,100
+10,400
+76% +$1.12M ﹤0.01% 1355
2023
Q2
$1.57M Sell
13,700
-24,000
-64% -$2.72M ﹤0.01% 1540
2023
Q1
$4M Sell
37,700
-21,500
-36% -$2.32M ﹤0.01% 1204
2022
Q4
$6.53M Buy
59,200
+29,200
+97% +$2.98M 0.01% 1141
2022
Q3
$2.6M Hold
30,000
﹤0.01% 1445
2022
Q2
$2.76M Buy
+30,000
New +$2.66M ﹤0.01% 1434
2020
Q4
Sell
-1,258
Closed -$100K 3103
2020
Q3
$100K Buy
+1,258
New +$98.5K ﹤0.01% 2619
2020
Q1
Sell
-50,514
Closed -$4.37M 2907
2019
Q4
$4.37M Sell
50,514
-251,415
-83% -$20.7M 0.01% 1162
2019
Q3
$24.3M Buy
301,929
+61,937
+26% +$4.96M 0.05% 461
2019
Q2
$19.2M Sell
239,992
-145,986
-38% -$11.2M 0.04% 516
2019
Q1
$30.6M Sell
385,978
-196,920
-34% -$14.7M 0.06% 352
2018
Q4
$42.5M Buy
582,898
+212,744
+57% +$15M 0.08% 260
2018
Q3
$25.1M Buy
370,154
+158,982
+75% +$10.1M 0.04% 466
2018
Q2
$12.2M Buy
211,172
+84,259
+66% +$4.75M 0.02% 712
2018
Q1
$6.6M Buy
+126,913
New +$6.85M 0.01% 1002
2017
Q4
Sell
-396,249
Closed -$24.2M 2284
2017
Q3
$24.2M Sell
396,249
-17,921
-4% -$1.09M 0.04% 467
2017
Q2
$25.3M Buy
414,170
+1,887
+0.5% +$115K 0.05% 437
2017
Q1
$25M Sell
412,283
-20,541
-5% -$1.25M 0.05% 403
2016
Q4
$24.3M Buy
432,824
+51,981
+14% +$3.04M 0.06% 413
2016
Q3
$22.7M Buy
380,843
+339,761
+827% +$19.9M 0.06% 386
2016
Q2
$2.26M Sell
41,082
-364,180
-90% -$19.4M 0.01% 1157
2016
Q1
$20.5M Buy
405,262
+37,204
+10% +$1.82M 0.06% 398
2015
Q4
$18.6M Buy
368,058
+362,818
+6,924% +$18.3M 0.04% 476
2015
Q3
$247K Sell
5,240
-32,079
-86% -$1.7M ﹤0.01% 1706
2015
Q2
$2.04M Sell
37,319
-52,390
-58% -$2.94M ﹤0.01% 1079
2015
Q1
$4.95M Sell
89,709
-42,025
-32% -$2.38M 0.01% 915
2014
Q4
$7.14M Sell
131,734
-8,593
-6% -$479K 0.01% 791
2014
Q3
$7.94M Sell
140,327
-66,234
-32% -$3.72M 0.02% 728
2014
Q2
$11.4M Buy
206,561
+107,420
+108% +$5.86M 0.02% 571
2014
Q1
$5.37M Sell
99,141
-70,635
-42% -$3.66M 0.01% 776
2013
Q4
$8.11M Sell
169,776
-4,192
-2% -$192K 0.02% 697
2013
Q3
$7.9M Buy
+173,968
New +$7.94M 0.02% 690

Other funds holding MRK

HSBC Holdings's MRK Position: Q1 2026 in Review

HSBC Holdings reduced its Merck (MRK) stake by 5.5% in Q1 2026, selling an estimated $51M and leaving 7,634,112 shares worth $918M. The position accounts for 0.48% of the portfolio, ranked #31.

HSBC Holdings first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.03B in Q2 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • HSBC Holdings held 7,634,112 shares of Merck worth $918M as of Q1 2026.
  • HSBC Holdings sold 441,337 Merck shares in Q1 2026, an estimated $51M.
  • Merck made up 0.48% of HSBC Holdings's portfolio in Q1 2026, its #31 holding.
  • HSBC Holdings first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's Merck position peaked at $1.03B in Q2 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.